Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07517562 · ClinicalTrials.gov registry record · NA

The Effects of Acute Erythropoietin on Hepcidin and Dietary Iron Absorption Following Military-relevant Exercise in Energy Deficit: Pilot Study

A NA study, sponsored by Pennington Biomedical Research Center.

Active
Registry status
NA
Development phase
6
Enrollment target

NCT07517562: Active NA study, sponsored by Pennington Biomedical Research Center.

NCT07517562 is a NA study that is active but no longer recruiting, run by Pennington Biomedical Research Center. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07517562, a NA study, is active but no longer recruiting, sponsored by Pennington Biomedical Research Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
6 participants
Enrollment target

Study Summary

Military personnel frequently experience declines in iron status during training and when in the field, which may compromise performance. The overall purpose of this study is to determine why the decline in iron status occurs and potential countermeasures. Participants will be given an acute dose of erythropoietin (EPO) or placebo and will complete a 90-minute load carriage exercise test. Prior to the main trial, this pilot study will determine the optimal approach to assess iron absorption following exercise (red blood cell incorporation or plasma isotope appearance), the percentage of iron incorporated into red blood cells with EPO compared to placebo, and the timing of the intervention.

Primary Outcome

Iron absorption as measured by iron incorporation into red blood cells

Interventions

  • OTHER Exercise test

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2025-09-01
Est. Completion 2026-05-01
Phase NA

What the registry record for NCT07517562 still lists

NCT07517562 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 1 intervention - of which Exercise test is the first listed.

NCT07517562 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07517562 about?

NCT07517562 is a clinical study titled "The Effects of Acute Erythropoietin on Hepcidin and Dietary Iron Absorption Following Military-relevant Exercise in Energy Deficit: Pilot Study". Military personnel frequently experience declines in iron status during training and when in the field, which may compromise performance. The overall purpose of this study is to determine why the decline in iron status occurs and potential countermeasures. Participants will be given an acute dose of...

What is the current status of trial NCT07517562?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 6 participants. The study started on 2025-09-01. Estimated completion is 2026-05-01.

What interventions are being tested in trial NCT07517562?

The interventions under investigation include: Exercise test (OTHER).

Who is sponsoring clinical trial NCT07517562?

This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07517562's enrollment target sits among peer trials

6 1983rd of 2000 higher than 13 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07517562, the US trial registry maintained by the National Library of Medicine. NCT07517562 (small enrollment · none site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.